Insider sale
TAYSHA GENE THERAPIES, INC.
$153.0K
30.05K shares
What this filing means
HAQUE-AHMED RUMANA plans to sell 30.05K shares of TAYSHA GENE THERAPIES, INC. valued at approximately $153.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/23/2026ACC: 0002086827-26-000004
30.05K
Shares to sell
$153.0K
Approx. market value
30.05K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
RSU Award
Vested grant settled in stock; consideration was Reporting Person's continued service as an employee of the Issuer.
1/23/2026
30.05KTotal acquired30.05K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/23/2026 | RSU Award Vested grant settled in stock; consideration was Reporting Person's continued service as an employee of the Issuer. | 30.05K | — |
| Total | 30.05K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
30.05K
Market value
$153.0K
1/23/2026
Total
Units
30.05K
Value
$153.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/23/2026 | 30.05K | $153.0K | Nasdaq | Planned |
| Total | 30.05K | $153.0K | ||